[
    [
        {
            "time": "2018-12-31",
            "original_text": "Here's Why Eli Lilly Stock Surged 37% in 2018",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock Surged",
                    "37%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Eli Lilly Stock Surged 37% in 2018",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",
            "features": {
                "keywords": [
                    "Biotech",
                    "Conferences",
                    "PDUFA Dates",
                    "Clinical Trials"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
            "features": {
                "keywords": [
                    "Loxo Oncology",
                    "Soared",
                    "66.4%",
                    "Another 66%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "oncology",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 10,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
            "features": {
                "keywords": [
                    "Loxo Oncology",
                    "Soared",
                    "66.4%",
                    "Another 66%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "oncology",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 10,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        }
    ]
]